Patterns and Management of Selected Adverse Events of Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • le Coutre, PD; Ceglarek, B; Turkina, A; Kim, D-W; Alimena, G; Al-Ali, HK; Shen, Z; Jootar, S; Smith, G; De Souza, CA; Rizzieri, DA; Szczudlo, T; Berton, M; Wang, J; Dial, E; Nicolini, FE

Published Date

  • November 20, 2009

Published In

Volume / Issue

  • 114 / 22

Start / End Page

  • 457 - 458

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 51st Annual Meeting of the American-Society-of-Hematology

Conference Location

  • New Orleans, LA

Conference Start Date

  • December 5, 2009

Conference End Date

  • December 8, 2009